2 Listed Companies, Orion Pharma Limited & Orion Infusion Limited discloses their third-quarter financials for the year ended (January 2024 – March 2024). This sources is known from DSE.
Orion Pharma: The company’s earnings per share (EPS) was Tk 0.42 paisa in Q3 of the current financial year (January – March 24). EPS was Tk 0.53 paisa during the same period last year. NAV per share was Tk. 93.01 on March 31, 2024.
Orion Infusion: The company’s earnings per share (EPS) was Tk 0.39 paisa in Q3 of the current financial year (January – March 24). EPS was Tk 0.38 paisa during the same period last year. NAV per share was Tk. 14.92 on March 31, 2024